Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 10—October 2008

Research

Prophylaxis after Exposure to Coxiella burnetii

Claire E. MoodieComments to Author , Herbert A. Thompson, Martin I. Meltzer, and David L. Swerdlow
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Table 3

Total medical cases averted because of postexposure prophylaxis*

Population No. cases averted
General population
All cases of illness 39,990
Severe illness 10,650
Deaths
480
High-risk population
All cases of illness 39,990
Severe illness 29,510
Deaths
3,538
Pregnant women†
All cases of illness 66,210
Severe illness 53,300
Deaths 22,394

*Accounting for best estimate drug-related adverse events, 82% drug efficacy, and 100% exposure.
†Includes the outcome of the unborn child.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO